Novavax (NVAX) Breaks Higher

December 2, 2009 · Filed Under flu 

Novavax, Inc. (NASDAQ: NVAX) is trading up again on swine flu or H1N1 news.  The company issued a press release showing positive clinical results from a pivotal study of H1N1 influenza vaccine in Mexico.  It is up 7% to $3.43.

Douglas A. McIntyre

Comments

Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed